文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

高通量单细胞 TCR-pMHC 解离速率测量由自主微流控细胞处理单元完成。

High-Throughput Single-Cell TCR-pMHC Dissociation Rate Measurements Performed by an Autonomous Microfluidic Cellular Processing Unit.

机构信息

Institute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland.

Ludwig Institute for Cancer Research, 1066 Lausanne, & Department of Oncology University of Lausanne & University Hospital of Lausanne (CHUV), 1066 Lausanne, Switzerland.

出版信息

ACS Sens. 2022 Jan 28;7(1):159-165. doi: 10.1021/acssensors.1c01935. Epub 2022 Jan 10.


DOI:10.1021/acssensors.1c01935
PMID:35006683
Abstract

We developed an integrated microfluidic cellular processing unit (mCPU) capable of autonomously isolating single cells and performing measurements and on-the-fly analysis of cell-surface dissociation rates, followed by recovery of selected cells. We performed proof-of-concept, high-throughput single-cell experiments characterizing pMHC-TCR interactions on live CD8+ T cells. The mCPU platform analyzed TCR-pMHC dissociation rates with a throughput of 50 cells per hour and hundreds of cells per run, and we demonstrate that cells can be selected, enriched, and easily recovered from the device.

摘要

我们开发了一种集成的微流控细胞处理单元(mCPU),能够自主分离单细胞,并对细胞表面解离率进行测量和实时分析,随后回收选定的细胞。我们进行了概念验证的高通量单细胞实验,对活 CD8+T 细胞上的 pMHC-TCR 相互作用进行了表征。mCPU 平台以每小时 50 个细胞和每次运行数百个细胞的通量分析 TCR-pMHC 解离率,并且我们证明可以从设备中选择、富集和轻松回收细胞。

相似文献

[1]
High-Throughput Single-Cell TCR-pMHC Dissociation Rate Measurements Performed by an Autonomous Microfluidic Cellular Processing Unit.

ACS Sens. 2022-1-28

[2]
High-Throughput Screening of Functional Neo-Antigens and Their Specific T-Cell Receptors via the Jurkat Reporter System Combined with Droplet Microfluidics.

Anal Chem. 2023-6-27

[3]
Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.

J Immunol. 2003-5-15

[4]
Quantitative TCR:pMHC Dissociation Rate Assessment by NTAmers Reveals Antimelanoma T Cell Repertoires Enriched for High Functional Competence.

J Immunol. 2015-7-1

[5]
CD8 kinetically promotes ligand binding to the T-cell antigen receptor.

Biophys J. 2005-9

[6]
Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living Cells.

Cancer Res. 2015-3-25

[7]
The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.

Eur J Immunol. 2009-8

[8]
Normalized Synergy Predicts That CD8 Co-Receptor Contribution to T Cell Receptor (TCR) and pMHC Binding Decreases As TCR Affinity Increases in Human Viral-Specific T Cells.

Front Immunol. 2017-7-28

[9]
Microfluidic T Cell Selection by Cellular Avidity.

Adv Healthc Mater. 2022-8

[10]
Direct single molecule measurement of TCR triggering by agonist pMHC in living primary T cells.

Elife. 2013-7-3

引用本文的文献

[1]
Recent advances in microfluidic-based cancer immunotherapy-on-a-chip strategies.

Biomicrofluidics. 2023-1-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索